Organisations registered to attend include:
65 Investors: 4BIO Capital, Abingworth, Advent Life Sciences, Albion Technology & General VCT, Amadeus Capital Partners, Anvil Partners, Arix Bioscience, Arrowfield Capital, Axilium Capital, Bioscience Managers, BioSeed Capital, Bridge Valley Ventures, Catapult Ventures, Curam Capital Management, DeBere Capital Partners, Deltec International Group, FastVentures, Glentworth Ventures, Hayfin Capital Management, Helsinn Investment Fund, Ignite Capital Partners, Industrifonden, INKEF Capital, Inkef Capital, Innovator Capital, Inventages Venture Capital, Investor Corporat, IPF Partners, JJDC, Julz Co, Longacre Funding partners, LSP, M Ventures, Masselos Family Office, MEDICXI, Mercia Technologies, Molecular Warehouse, Momentum Biotech, MVM Partners, National Institute for Health Research, NCL Technology Ventures, Newable Private Investing, New Science Fund, Norgine Ventures, Novo Seeds, Novo Ventures, NVM, Optum Ventures, Panakes Partners, Rosetta Capital, Rothschild, S.R.One, SBA, Seroba Life Sciences, Seventure, Sofinnova, Start Codon, Sunstone Life Science Ventures, The Cure Parkinson’s Trust, Trillium Medical Ventures, UCL Technology Fund, UKI2S, Velocity Fund Partners, Vivanova.
Delegates: Abbvie, Ablatus Therapeutics, AstraZeneca, Bayer, Eli Lilly, Johnson and Johnson Innovation, Merck, Otsuka Europe, Ablatus Therapeutics, Acesion Pharma, Adenium Biotech, Antagonis, Apitope, Arcus Altor, Arterial Capital Management, Artios Pharma, Asceneuron, Athena Market Access Solutions, AVILLION, BioCentury Publications, BioPartner UK, Biotec Pharmacon, BTG, Calliditas, Censo Biotechnologies, CMR Surgical, COMPASS Pathways, Cumulus Oncology, Department for International Trade, Drug Discovery Today, Embassy of Spain in London, EP Vantage, Eurofins Amatsigroup, Evox Therapeutics, Ezenze, F2G, Fusion Antibodies, Global Regulatory Services, ImaginAB, International Biotechnology Trust, Invest in Denmark, Embassy of Denmark, ISA Therapeutics, J A Kemp, Jefferies, Labiotech.eu, Lavivo, London Business School, LSX, Masters Speciality Pharma, Medherant, Medicon Valley Alliance, MediSieve Limited, Meeting Mojo, Mission Therapeutics, Nature Biotechnology, One Nucleus, Optimum Strategic Communications, Oxford Cardiomox, NMD Pharma, Parkinson’s Concierge, PCI Clinical Services, Pebmond Associates, Pharma Publications, Prophylix, Public Health England, RDP Life Sciences, ReNeuron, River Stone, RTC S.p.A., RYSE Asset Management, Sartar Therapeutics, Scrip, Silicon Valley Bank, SIME Clinical AI, Sygnature Discovery, UK BioIndustry Association (BIA), University of Dundee, VAXIMM, Verdict, Virokine Therapeutics, William Reed, Xenogesis, Zerion.

For conference registration, we use